Annual report pursuant to Section 13 and 15(d)

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (Details)

v3.22.0.1
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
SEC Schedule, 12-09, Allowance, Credit Loss [Member]      
Valuation allowances and reserves [Roll Forward]      
Balance at Beginning of Period $ 72,904 $ 50,516 $ 34,225
Charges of Costs, Expenses and Other (17,658) 26,103 24,419
Write-off of Accounts Receivable 3,846 11,901 7,968
Other [1] (909) 8,186 (160)
Balance at End of Period 50,491 72,904 50,516
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]      
Valuation allowances and reserves [Roll Forward]      
Balance at Beginning of Period 1,100,407 667,242 530,642
Charges of Costs, Expenses and Other 135,908 344,161 8,536
Deletions 0 0 0
Other [2] (16,819) 89,004 128,064
Balance at End of Period $ 1,219,496 $ 1,100,407 $ 667,242
[1] Foreign currency adjustments, acquisitions and miscellaneous adjustments. The year ended December 31, 2020 includes a $3.0 million cumulative-effect adjustment related to our adoption of the accounting guidance for current expected credit losses for financial assets measured at amortized cost.
[2] During 2021, 2020 and 2019, the valuation allowance was adjusted for acquisitions, divestitures and foreign currency adjustments. The 2019 and 2020 valuation allowance increased due to increases in fully valued deferred tax assets, primarily net operating loss carryforwards. The 2021 valuation allowance increased primarily due to increases in certain fully valued United States federal deferred tax assets.